# Hypertonic Saline to Reduce Hospital Admissions in Bronchiolitis

> **NCT00677729** · PHASE2 · COMPLETED · sponsor: **Queen's University** · enrollment: 81 (actual)

## Conditions studied

- Viral Bronchiolitis

## Interventions

- **DRUG:** solution contains 1 mg salbutamol plus 3% hypertonic saline
- **DRUG:** solution contains 1 mg salbutamol plus 0.9% saline

## Key facts

- **NCT ID:** NCT00677729
- **Lead sponsor:** Queen's University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-11
- **Primary completion:** 2009-04
- **Final completion:** 2009-05
- **Target enrollment:** 81 (ACTUAL)
- **Last updated:** 2015-11-13

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00677729

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00677729, "Hypertonic Saline to Reduce Hospital Admissions in Bronchiolitis". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT00677729. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*